Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
The DOI matches its Crossref record; 23 of the 26 references it cites were found in a registry or an index.
Abstract
We analyzed data from the National Nosocomial Infections Surveillance (NNIS) System from 1986-2003 to determine the epidemiology of gram-negative bacilli in intensive care units (ICUs) for the most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI). We analyzed >410,000 bacterial isolates associated with hospital-acquired infections in ICUs during 1986-2003. In 2003, gram-negative bacilli were associated with 23.8% of BSIs, 65.2% of pneumonia episodes, 33.8% of SSIs, and 71.1% of UTIs. The percentage of BSIs associated with gram-negative bacilli decreased from 33.2% in 1986 to 23.8% in 2003. The percentage of SSIs associated with gram-negative bacilli decreased from 56.5% in 1986 to 33.8% in 2003. The percentages pneumonia episodes and UTIs associated with gram-negative bacilli remained constant during the study period. The proportion of ICU pneumonia episodes associated with Acinetobacter species increased from 4% in 1986 to 7.0% in 2003 (P<.001, by the Cochran-Armitage chi2 test for trend). Significant increases in resistance rates were uniformly seen for selected antimicrobial-pathogen combinations. Gram-negative bacilli are commonly associated with hospital-acquired infections in ICUs. The proportion of Acinetobacter species associated with ICU pneumonia increased from 4% in 1986 to 7.0% in 2003.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a group, these organisms are the most common etiology of nosocomial infections, including most cases of hospital-acquired pneumonia, ventilator-associated pneumonia and healthcare-associated pneumonia, and they are important causes of morbidity and death in hospitalized patients (1).”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [1]
Citations
Cites
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
Hospital Epidemiology and Infection Control
Mayhall, C. G. (2011) · Cited by 1,179
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Self-citationSurveillance nosokomialer Infektionen
Gastmeier (2004) · Therapeutische Umschau · doi:10.1024/0040-5930.61.3.204 · Cited by 509
Epidemiology and control of nosocomial infections in adult intensive care units
Weinstein, R. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90366-6 · Cited by 300 · cited 1×
“the 4 most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI) [1].”
BackgroundSelf-citationMultidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285 · cited 1×
“Acinetobacter organisms are intrinsically resistant to many antimicrobials and can acquire resistance to others [7].”
BackgroundHOSPITAL ACQUIRED INFECTIONS: KNOWLEDGE ABOUT IT AND ITS PREVENTION
QAYYUM, S., WAQAS, B., & SATTAR, A. (2010) · The Professional Medical Journal · doi:10.29309/tpmj/2010.17.02.2211 · Cited by 256
MAGNITUDE AND PREVENTION OF NOSOCOMIAL INFECTIONS IN THE INTENSIVE CARE UNIT
Fridkin, S. K., Welbel, S. F., & Weinstein, R. A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70366-4 · Cited by 225 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
BackgroundSelf-citationStreit, J. M., Jones, R. N., Sader, H. S., & Fritsche, T. R. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.019 · Cited by 191
Syncope and orthostatic hypotension
Atkins, D., Hanusa, B., Sefcik, T., & Kapoor, W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90012-m · Cited by 172
Research works printed but not linked: 2
- 1991, The American journal of medicine, 91, 86
- Richards, 2003, Annals of surgery, 237, 358, 10.1097/00000658-200303000-00009 · doi:10.1097/00000658-200303000-00009
Cited by
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
“coli has increased significantly as has imipenem and ceftazidine resistance among Pseudomonas aeruginosa.(209) Candida spp.”
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
“6% of ICU-acquired UTIs in one study (187).”
BackgroundInfluentialClinical practice guidelines for antimicrobial prophylaxis in surgery
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., et al. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp120568 · Cited by 2,591
Self-citationLister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
“aeruginosa as the second most common cause of nosocomial pneumonia, health care-associated pneumonia, and ventilator-associated pneumonia (64, 106) and the leading cause of pneumonia among pediatric patients in the intensive care unit (ICU) (214).”
BackgroundLoveday, H. P., Wilson, J. A., Pratt, R. J., Golsorkhi, M., Tingle, A., Bak, A., Browne, J., Prieto, J., & Wilcox, M. (2014) · Journal of Hospital Infection · doi:10.1016/s0195-6701(13)60012-2 · Cited by 1,621
Hospital-Acquired Infections Due to Gram-Negative Bacteria
Peleg, A. Y., & Hooper, D. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0904124 · Cited by 1,495
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., et al. (2013) · Surgical Infections · doi:10.1089/sur.2013.9999 · Cited by 1,197
Self-citationGlobal Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
“The statistics compiled as a result of surveillance efforts illustrate the emergence of many genera of bacteria that are resistant to all antibiotics (57, 60).”
BackgroundTalbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Self-citationGuidelines for the prevention of intravascular catheter-related infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.01.003 · Cited by 1,066
“For example, CLABSI is a term used by CDC's National Healthcare Safety Network (NHSN) (NHSN CLABSI information: http://www.cdc.gov/nhsn/psc_da.html) [206].”
InfluentialThe Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
Driscoll, J. A., Brody, S. L., & Kollef, M. H. (2007) · Drugs · doi:10.2165/00003495-200767030-00003 · Cited by 884
Acinetobacter baumannii: An emerging opportunistic pathogen
Howard, A., O’Donoghue, M., Feeney, A., & Sleator, R. D. (2012) · Virulence · doi:10.4161/viru.19700 · Cited by 837
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
Bonomo, R. A., & Szabo, D. (2006) · Clinical Infectious Diseases · doi:10.1086/504477 · Cited by 741
“ble for hospital-acquired infections [2].”
Ayoub Moubareck, C., & Hammoudi Halat, D. (2020) · Antibiotics · doi:10.3390/antibiotics9030119 · Cited by 627
“6% of ICU-acquired UTIs in one study [52].”
BackgroundHospital Epidemiology and Infection Control in Acute-Care Settings
Sydnor, E. R. M., & Perl, T. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-10 · Cited by 652
Gorrie, C. L., Mirčeta, M., Wick, R. R., Edwards, D. J., Thomson, N. R., Strugnell, R. A., Pratt, N. F., Garlick, J. S., Watson, K. M., Pilcher, D. V., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix270 · Cited by 576
Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models
McConnell, M. J., Actis, L., & Pachón, J. (2013) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00344.x · Cited by 540
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
The role of natural environments in the evolution of resistance traits in pathogenic bacteria
Martinez, J. L. (2009) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2009.0320 · Cited by 513
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
Karageorgopoulos, D. E., & Falagas, M. E. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70279-2 · Cited by 446
Elfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374466 · Cited by 340
“(Gaynes and Edwards, 2005).”
Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes
Hirsch, E. B., & Tam, V. H. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.49 · Cited by 406
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Sunenshine, R. H., Wright, M.-O., Maragakis, L. L., Harris, A. D., Song, X., Hebden, J., Cosgrove, S. E., Anderson, A., Carnell, J., Jernigan, D. B., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060716 · Cited by 411
“The proportion of healthcare-associated infections caused by Acinetobacter spp. has increased over the past decade in the United States (4).”
BackgroundCiprofloxacin derivatives and their antibacterial activities
Zhang, G.-F., Liu, X., Zhang, S., Pan, B., & Liu, M.-L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.078 · Cited by 390
Choi, A. H. K., Slamti, L., Avci, F. Y., Pier, G. B., & Maira-Litrán, T. (2009) · Journal of Bacteriology · doi:10.1128/jb.00647-09 · Cited by 387
“baumannii strains has been on the rise in the last two decades (9).”
BackgroundKempf, M., & Rolain, J.-M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.10.004 · Cited by 389
Lockhart, S. R., Abramson, M. A., Beekmann, S. E., Gallagher, G., Riedel, S., Diekema, D. J., Quinn, J. P., & Doern, G. V. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01284-07 · Cited by 396
Perez, K. K., Olsen, R. J., Musick, W. L., Cernoch, P. L., Davis, J. R., Land, G. A., Peterson, L. E., & Musser, J. M. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0651-oa · Cited by 388
An overview of the use of nanozymes in antibacterial applications
Mei, L., Zhu, S., Liu, Y., Yin, W., Gu, Z., & Zhao, Y. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129431 · Cited by 369
Mauldin, P. D., Salgado, C. D., Hansen, I. S., Durup, D. T., & Bosso, J. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01041-09 · Cited by 360
The role of vaccines in preventing bacterial antimicrobial resistance
Jansen, K. U., Knirsch, C., & Anderson, A. S. (2018) · Nature Medicine · doi:10.1038/nm.4465 · Cited by 355
Guidelines for the Prevention of Intravascular Catheter–Related Infections
O'Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., et al. (2002) · Infection Control & Hospital Epidemiology · doi:10.1017/s0195941700080577 · Cited by 319
Self-citationA global view of antibiotic resistance
Martinez, J. L., Fajardo, A., Garmendia, L., Hernandez, A., Linares, J. F., Martínez-Solano, L., & Sánchez, M. B. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00142.x · Cited by 356
“: +34 915854542; fax: +34 915854506; e-mail: jlmtnez@cnb.csic.es Present address: Juan Francisco Linares, Department of Molecular Oncogenesis, Genome Research Institute, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.”
BackgroundNathwani, D., Raman, G., Sulham, K., Gavaghan, M., & Menon, V. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-32 · Cited by 344
“aeruginosa is the most common Gram-negative pathogen causing nosocomial pneumonia in the United States, and it is frequently implicated in hospital-acquired urinary tract and bloodstream infections [2-4].”
BackgroundAlavarse, A. C., de Oliveira Silva, F. W., Colque, J. T., da Silva, V. M., Prieto, T., Venancio, E. C., & Bonvent, J.-J. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.03.199 · Cited by 340
Russo, T. A., Luke, N. R., Beanan, J. M., Olson, R., Sauberan, S. L., MacDonald, U., Schultz, L. W., Umland, T. C., & Campagnari, A. A. (2010) · Infection and Immunity · doi:10.1128/iai.00366-10 · Cited by 324
“The incidence of Acinetobacter baumannii infection in all venues is increasing worldwide (17, 20, 32, 34).”
BackgroundTängdén, T., & Giske, C. G. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12342 · Cited by 322
Acinetobacter infection – an emerging threat to human health
Visca, P., Seifert, H., & Towner, K. J. (2011) · IUBMB Life · doi:10.1002/iub.534 · Cited by 324
Impedance-Based Detection of Bacteria
Furst, A. L., & Francis, M. B. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00381 · Cited by 321
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Vázquez-López, R., Solano-Gálvez, S. G., Juárez Vignon-Whaley, J. J., Abello Vaamonde, J. A., Padró Alonzo, L. A., Rivera Reséndiz, A., Muleiro Álvarez, M., Vega López, E. N., Franyuti-Kelly, G., Álvarez-Hernández, D. A., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9040205 · Cited by 296
“They confirmed a significant increase in MDR ABC isolates (14% in 1995 to 26% in 2004) [14,15].”
BackgroundResistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum
McGowan, J. E. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.226 · Cited by 312
Falagas, M. E., & Kopterides, P. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.04.015 · Cited by 305
Pathogenesis of Gram-Negative Bacteremia
Holmes, C. L., Anderson, M. T., Mobley, H. L. T., & Bachman, M. A. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00234-20 · Cited by 277
Falkinham, J. O., Hilborn, E. D., Arduino, M. J., Pruden, A., & Edwards, M. A. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1408692 · Cited by 277
“Although a proportion of CF patients are infected with P. aeruginosa from other patients (cohabitating hospital wards), the major source of infection is water (Geddes 2008; Hayes et al. 2010).”
Porto, W. F., Irazazabal, L., Alves, E. S. F., Ribeiro, S. M., Matos, C. O., Pires, Á. S., Fensterseifer, I. C. M., Miranda, V. J., Haney, E. F., Humblot, V., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03746-3 · Cited by 284
Isolation and Characterization of an Autoinducer Synthase from Acinetobacter baumannii
Niu, C., Clemmer, K. M., Bonomo, R. A., & Rather, P. N. (2008) · Journal of Bacteriology · doi:10.1128/jb.01929-07 · Cited by 279
“A. baumannii is an important nosocomial pathogen and can cause a variety of infections including wound infections, bloodstream infections, ventilator-acquired pneumonia, and urinary tract infections (2, 5, 6, 11, 13, 14 , 21, 23, 31, 41, 43).”
BackgroundPneumonia Due to Pseudomonas aeruginosa
Fujitani, S., Sun, H.-Y., Yu, V. L., & Weingarten, J. A. (2011) · Chest · doi:10.1378/chest.10-0166 · Cited by 273
Iacono, M., Villa, L., Fortini, D., Bordoni, R., Imperi, F., Bonnal, R. J. P., Sicheritz-Ponten, T., De Bellis, G., Visca, P., Cassone, A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01643-07 · Cited by 273
“It is responsible for large outbreaks of nosocomial infection which account for 2 to 10% of all infections caused by gram-negative bacteria, with the highest incidence occurring in intensive care units (ICUs) ( 17 , 18).”
BackgroundFalagas, M. E., Bliziotis, I. A., & Siempos, I. I. (2006) · Critical Care · doi:10.1186/cc4869 · Cited by 272
“baumannii has been recognized as a leading cause of nosocomial pneumonia and bacteremia (related to central venous catheters or not) in several hospitals in various parts of the world [3-6].”
BackgroundCharacterization of Antimicrobial Peptides toward the Development of Novel Antibiotics
Aoki, W., & Ueda, M. (2013) · Pharmaceuticals · doi:10.3390/ph6081055 · Cited by 252
“Gram-negative bacteria are one of the major causes of hospital-acquired infections [139].”
BackgroundInnate immune responses to Pseudomonas aeruginosa infection
Lavoie, E. G., Wangdi, T., & Kazmierczak, B. I. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.07.011 · Cited by 235
Hood, M. I., Mortensen, B. L., Moore, J. L., Zhang, Y., Kehl-Fie, T. E., Sugitani, N., Chazin, W. J., Caprioli, R. M., & Skaar, E. P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003068 · Cited by 255
“antibiotic resistance determinants [1–6].”
Chopra, I., Schofield, C., Everett, M., O'Neill, A., Miller, K., Wilcox, M., Frère, J.-M., Dawson, M., Czaplewski, L., Urleb, U., et al. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70018-5 · Cited by 243
Convergence of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Infection
Roy, S., Chowdhury, G., Mukhopadhyay, A. K., Dutta, S., & Basu, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.793615 · Cited by 213
Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem
Rehman, A., Patrick, W. M., & Lamont, I. L. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000873 · Cited by 226
Smith, R. S., Zhang, Z., Bouchard, M., Li, J., Lapp, H. S., Brotske, G. R., Lucchino, D. L., Weaver, D., Roth, L. A., Coury, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004120 · Cited by 221
Antimicrobial Resistance in Hospital-Acquired Gram-Negative Bacterial Infections
Mehrad, B., Clark, N. M., Zhanel, G. G., & Lynch, J. P. (2015) · Chest · doi:10.1378/chest.14-2171 · Cited by 220
Nanocomposite materials for photocatalytic degradation of pollutants
Petronella, F., Truppi, A., Ingrosso, C., Placido, T., Striccoli, M., Curri, M. L., Agostiano, A., & Comparelli, R. (2017) · Catalysis Today · doi:10.1016/j.cattod.2016.05.048 · Cited by 224
Growth and Laboratory Maintenance of Pseudomonas aeruginosa
LaBauve, A. E., & Wargo, M. J. (2012) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc06e01s25 · Cited by 208
Ruden, S., Hilpert, K., Berditsch, M., Wadhwani, P., & Ulrich, A. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01106-08 · Cited by 225
He, X., Lu, F., Yuan, F., Jiang, D., Zhao, P., Zhu, J., Cheng, H., Cao, J., & Lu, G. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00877-15 · Cited by 220
4-Quinolone hybrids and their antibacterial activities
Hu, Y.-Q., Zhang, S., Xu, Z., Lv, Z.-S., Liu, M.-L., & Feng, L.-S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.050 · Cited by 219
Knezevic, P., Aleksic, V., Simin, N., Svircev, E., Petrovic, A., & Mimica-Dukic, N. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.008 · Cited by 205
Morgan, D. J., Liang, S. Y., Smith, C. L., Johnson, J. K., Harris, A. D., Furuno, J. P., Thorn, K. A., Snyder, G. M., Day, H. R., & Perencevich, E. N. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/653201 · Cited by 204
Gram-negative antibiotic resistance: there is a price to pay
Slama, T. G. (2008) · Critical Care · doi:10.1186/cc6820 · Cited by 206
ZnO-based antimicrobial coatings for biomedical applications
Puspasari, V., Ridhova, A., Hermawan, A., Amal, M. I., & Khan, M. M. (2022) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-022-02733-9 · Cited by 188
“As previously mentioned, nosocomial infection is caused by bacteria or viruses and typically incubating at the time of admission [11, 12].”
BackgroundLolans, K., Rice, T. W., Munoz-Price, L. S., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-06 · Cited by 202
Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum
McGowan, J. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.014 · Cited by 192
van Faassen, H., KuoLee, R., Harris, G., Zhao, X., Conlan, J. W., & Chen, W. (2007) · Infection and Immunity · doi:10.1128/iai.00762-07 · Cited by 196
“During the last decade, this organism has emerged as a major cause of both community-associated and nosocomial infections worldwide ( 11 , 14).”
BackgroundLandman, D., Bratu, S., Kochar, S., Panwar, M., Trehan, M., Doymaz, M., & Quale, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm129 · Cited by 192
El Haddad, L., Harb, C. P., Gebara, M. A., Stibich, M. A., & Chemaly, R. F. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy947 · Cited by 185
Multiresistant Gram-negative infections: a global perspective
Ho, J., Tambyah, P. A., & Paterson, D. L. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833f0d3e · Cited by 189
Bioprospecting Sponge-Associated Microbes for Antimicrobial Compounds
Indraningrat, A., Smidt, H., & Sipkema, D. (2016) · Marine Drugs · doi:10.3390/md14050087 · Cited by 188
Surgical site infections: Causative pathogens and associated outcomes
Weigelt, J. A., Lipsky, B. A., Tabak, Y. P., Derby, K. G., Kim, M., & Gupta, V. (2010) · American Journal of Infection Control · doi:10.1016/j.ajic.2009.06.010 · Cited by 190
Pseudomonas aeruginosa in premise plumbing of large buildings
Bédard, E., Prévost, M., & Déziel, E. (2016) · MicrobiologyOpen · doi:10.1002/mbo3.391 · Cited by 172
Mpogoro, F. J., Mshana, S. E., Mirambo, M. M., Kidenya, B. R., Gumodoka, B., & Imirzalioglu, C. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-25 · Cited by 182
“Enteric gram-negative bacteria have previously been reported to be associated with severe SSI [27,28] .”
BackgroundMechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection
Curran, C. S., Bolig, T., & Torabi-Parizi, P. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-1043so · Cited by 182
Johnson, L., Mulcahy, H., Kanevets, U., Shi, Y., & Lewenza, S. (2012) · Journal of Bacteriology · doi:10.1128/jb.05230-11 · Cited by 174
“aeruginosa is also a major cause of hospital-acquired infections, many of which are due to biofilm colonization of medical implant devices or respirators (14).”
BackgroundShorr, A. F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ced02 · Cited by 181
“The proportion of Enterobacteriaceae resistant to thirdgeneration cephalosporins increased between 1986 and 2003, rising nearly tenfold among Klebsiella pneumoniae and more than two-fold among Escherichia coli (1).”
BackgroundHospital Wastewater Releases of Carbapenem-Resistance Pathogens and Genes in Urban India
Lamba, M., Graham, D. W., & Ahammad, S. Z. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b03380 · Cited by 180
Treatment of Acinetobacter infections
Michalopoulos, A., & Falagas, M. E. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003596350 · Cited by 180
Surface-grafted polysarcosine as a peptoid antifouling polymer brush
Lau, K. H. A., Ren, C., Sileika, T. S., Park, S. H., Szleifer, I., & Messersmith, P. B. (2012) · Langmuir · doi:10.1021/la302131n · Cited by 178
Prevention of Surgical Site Infection
Kirby, J. P., & Mazuski, J. E. (2009) · Surgical Clinics of North America · doi:10.1016/j.suc.2009.01.001 · Cited by 165
Antimicrobial activity of transition metal acid MoO3 prevents microbial growth on material surfaces
Zollfrank, C., Gutbrod, K., Wechsler, P., & Guggenbichler, J. P. (2012) · Materials Science and Engineering: C · doi:10.1016/j.msec.2011.09.010 · Cited by 163
Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
Bartal, C., Rolston, K. V. I., & Nesher, L. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00597-w · Cited by 159
Lees‐Miller, R. G., Iwashkiw, J. A., Scott, N. E., Seper, A., Vinogradov, E., Schild, S., & Feldman, M. F. (2013) · Molecular Microbiology · doi:10.1111/mmi.12300 · Cited by 164
Eveillard, M., Kempf, M., Belmonte, O., Pailhoriès, H., & Joly-Guillou, M.-L. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.03.021 · Cited by 161
Hua, Y., Luo, T., Yang, Y., Dong, D., Wang, R., Wang, Y., Xu, M., Guo, X., Hu, F., & He, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02659 · Cited by 166
“Acinetobacter baumannii mainly affects elderly patients with compromised immune systems and always leads to negative 4http://www.ncbi.nlm.nih.gov/pubmed, accessed March 15, 2017 Frontiers in Microbiology | www.frontiersin.org 8 January 2018 | Volume 8 | Article 2659 outcomes (Gaynes et al., 2005).”
BackgroundComplicated Urinary Tract Infections
Neal, D. E. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2007.09.010 · Cited by 165
Kim, S. W., Choi, C. H., Moon, D. C., Jin, J. S., Lee, J. H., Shin, J.-H., Kim, J. M., Lee, Y. C., Seol, S. Y., Cho, D. T., et al. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01820.x · Cited by 163
Ledeboer, N. A., Lopansri, B. K., Dhiman, N., Cavagnolo, R., Carroll, K. C., Granato, P., Thomson, R., Butler-Wu, S. M., Berger, H., Samuel, L., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00581-15 · Cited by 164
Kang, D., Kirienko, D. R., Webster, P., Fisher, A. L., & Kirienko, N. V. (2018) · Virulence · doi:10.1080/21505594.2018.1449508 · Cited by 183
Pitout, J. D. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.110 · Cited by 161
Niederman, M. S., Chastre, J., Corkery, K., Fink, J. B., Luyt, C.-E., & García, M. S. (2012) · Intensive Care Medicine · doi:10.1007/s00134-011-2420-0 · Cited by 168
Advances in pathogenesis and management of sepsis
Cinel, I., & Dellinger, R. P. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32818be70a · Cited by 160
Russo, T. A., Beanan, J. M., Olson, R., MacDonald, U., Cox, A. D., Michael, F. S., VINOGRADOV, E. V., Spellberg, B. J., Luke‐Marshall, N. R., & Campagnari, A. A. (2013) · Infection and Immunity · doi:10.1128/iai.01184-12 · Cited by 159
Vaccines for Pseudomonas aeruginosa : a long and winding road
Priebe, G. P., & Goldberg, J. B. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.890053 · Cited by 175
“aeruginosa continues to cause serious infections in humans, particularly in the critically ill [6], the immunocompromised [7,8], those with burn wounds [9] or combat-related wound infections [10,11] and those with cystic fibrosis (CF) [12].”
BackgroundGenome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii
Snitkin, E. S., Zelazny, A. M., Montero, C. I., Stock, F., Mijares, L. A., Program, N. C. S., Murray, P. R., Segre, J. A., Mullikin, J. C., Blakesley, R. W., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104404108 · Cited by 158
Tsukatani, T., Suenaga, H., Shiga, M., Noguchi, K., Ishiyama, M., Ezoe, T., & Matsumoto, K. (2012) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2012.05.001 · Cited by 165
“Infections due to multidrug-resistant Pseudomonas aeruginosa (MDRP) (Gaynes and Edwards, 2005; Pagani et al., 2005; Sekiguchi et al., 2007), multidrugresistant Acinetobacter baumannii (Dijkshoorn et al., 2007; Gaynes and Edwards, 2005; Higgins et al., 2010), and carbapenemase-producing Klebsiella…”
BackgroundInfluential
Metadata
- Authors
- Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-15
- Volume
- 41
- Issue
- 6
- Pages
- 848-854
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2151958462
- Cited by
- 1,404
- References
- 26
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 37 · 2023: 56 · 2022: 73 · 2021: 80 · 2020: 66 · 2019: 78 · 2018: 66 · 2017: 74 · 2016: 86 · 2015: 89 · 2014: 85 · 2013: 95 · 2012: 85
- FWCI
- 38.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial infections, Gram-negative bacilli, intensive care unit, surgical site infection, urinary tract infection, bloodstream infection, Acinetobacter, antimicrobial resistance, epidemiological trends
- MeSH terms
- Cross Infection, Gram-Negative Bacteria, Humans, National Health Programs, Population Surveillance, Surgical Wound Infection, Time Factors, United States, Urinary Tract Infections, Gram-Negative Bacterial Infections, Pneumonia, Bacterial, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.